These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2455078)

  • 21. Anti-cyclic citrullinated peptide antibodies in psoriasis patients without arthritis.
    Böckelmann R; Gollnick H; Bonnekoh B
    Arthritis Rheum; 2006 May; 54(5):1701-2. PubMed ID: 16646043
    [No Abstract]   [Full Text] [Related]  

  • 22. Relationship between tektins and intermediate filament proteins: an immunological study.
    Steffen W; Linck RW
    Cell Motil Cytoskeleton; 1989; 14(3):359-71. PubMed ID: 2582496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New autoantibodies in rheumatoid arthritis.
    Le Goff P; Saraux A; Youinou P
    Rev Rhum Engl Ed; 1997 Nov; 64(11):638-44. PubMed ID: 9413888
    [No Abstract]   [Full Text] [Related]  

  • 24. Antivimentin autoantibodies in angioimmunoblastic lymphadenopathy.
    Dellagi K; Brouet JC; Seligmann M
    N Engl J Med; 1984 Jan; 310(4):215-8. PubMed ID: 6197653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Keratin and filaggrin expression in keratoacanthoma.
    Ito Y; Kurokawa I; Nishimura K; Hakamada A; Isoda K; Yamanaka K; Tsubura A; Mizutani H
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):353-5. PubMed ID: 18005116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New markers and an old phenomenon: prozone effect disturbing detection of filaggrin (keratin) autoantibodies.
    Dubois-Galopin F; Beauvillain C; Dubois D; Pillet A; Renier G; Jeannin P; Masson C; Chevailler A
    Ann Rheum Dis; 2007 Aug; 66(8):1121-2. PubMed ID: 17626972
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antiperinuclear factors in psoriasis. Correlation with other serological abnormalities in 90 patients].
    Youinou P; Massé R; Peu-Duvallon P; Le Roux P; Grulier A; Miossec P; Dorval JC; Lizan G; Férec C; Le Goff P
    Ann Dermatol Venereol; 1982; 109(4):359-64. PubMed ID: 6751193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pachyonychia congenita. Immunohistologic findings.
    Wollina U; Schaarschmidt H; Fünfstück V; Knopf B
    Zentralbl Pathol; 1991; 137(4):372-5. PubMed ID: 1722707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.
    Simon M; Girbal E; Sebbag M; Gomès-Daudrix V; Vincent C; Salama G; Serre G
    J Clin Invest; 1993 Sep; 92(3):1387-93. PubMed ID: 7690781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of antikeratin antibodies in patients with palmoplantar pustular eruptions and arthropathy.
    Jurik AG; Graudal H; Kirstein H
    Arch Dermatol Res; 1989; 281(3):185-7. PubMed ID: 2476081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-keratin antibodies: their significance in the diagnosis and prognosis of systemic connective tissue diseases].
    Małdyk E
    Pol Tyg Lek; 1987 Jan; 42(2):35-7. PubMed ID: 2438669
    [No Abstract]   [Full Text] [Related]  

  • 32. [Infectious allergy and autoimmune process in patients with psoriasis suffering from chronic tonsillitis].
    Korolev IuF; Iakhnitskiĭ GG
    Vestn Dermatol Venerol; 1977 Aug; (8):7-10. PubMed ID: 930316
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunohistochemical detection of intermediate filament proteins in formalin fixed normal and neoplastic canine tissues.
    Desnoyers MM; Haines DM; Searcy GP
    Can J Vet Res; 1990 Jun; 54(3):360-5. PubMed ID: 1696160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antiperinuclear and antikeratin antibodies in liver diseases].
    Youinou P; Miossec P; Pennec Y; Boles JM; Le Goff P; Le Menn G
    Sem Hop; 1983 Mar; 59(9):589-92. PubMed ID: 6190231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-keratin antibodies in rheumatoid arthritis: frequency and correlation with other features of the disease.
    Mallya RK; Young BJ; Pepys MB; Hamblin TJ; Mace BE; Hamilton EB
    Clin Exp Immunol; 1983 Jan; 51(1):17-20. PubMed ID: 6187504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoelectron microscopic identification of upper cytoplasmic antigens on keratin intermediate filaments.
    Thivolet J
    J Invest Dermatol; 1985 Jun; 84(6):542-3. PubMed ID: 2582063
    [No Abstract]   [Full Text] [Related]  

  • 37. Estimation of (IgA) anti-gliadin, anti-endomysium and tissue transglutaminase in the serum of patients with psoriasis.
    Nagui N; El Nabarawy E; Mahgoub D; Mashaly HM; Saad NE; El-Deeb DF
    Clin Exp Dermatol; 2011 Apr; 36(3):302-4. PubMed ID: 21418272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Predictive factors in prognosis of rheumatoid arthritis].
    Matsuda T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():19-23. PubMed ID: 15799311
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The detection of human antibodies against cytoskeletal components.
    Kurki P; Virtanen I
    J Immunol Methods; 1984 Mar; 67(2):209-23. PubMed ID: 6200533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.